Society For Interventional Radiology Annual Meeting In Brief
This article was originally published in The Gray Sheet
UFE success post-menopause: Northwestern University scientists present April 3 at the Society of Interventional Radiology's annual meeting in Toronto that uterine fibroid embolization produced symptom improvements in 22 of 25 post-menopausal women during two years of follow-up. The technique, in which tiny spherical particles are released into uterine arteries to kill fibroid tumors by blocking their blood supply, is an accepted minimally invasive first-line therapy for fibroid disease in symptomatic pre-menopausal women, but the evidence in post-menopausal women is lacking, according to the researchers...
You may also be interested in...
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.
Lannett has begun marketing a US rival to Adderall XR through a partnership with Elite and SunGen. But the product will face competition from a range of other generics.